3186 results for «3543»
3186 results
Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme
20 May 2021 – From EuroPCR 2021
Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
Next-generation TAVR device will enable lifetime management of aortic stenosis patients
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance...
Efficient TAVI in the context of expanding indications?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard and Didier Tchetche in order to review latest data from the Evolut low-risk trial and the OptimizePro study, to learn more about latest TAVI patient pathway efficiency and economics evidence, and to discover how to translate these insights locally and enable you...
The power of Big Data: can a network meta-analysis reveal the true performance of a DES?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Tullio Palmerini in order to learn about the recently published Network Meta-Analysis on TLF with current DES, to review the role of ultrathin DES in optimising clinical outcomes, and to assess the impact of the results on your daily practice.
FFR-guided PCI optimisation directed by high-definition IVUS
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen in order to understand the rationale of low post-PCI FFR, to learn if and how post-PCI FFR can be improved, and to know more about the risk of post-PCI optimisation.
Early real-world experience with Tendyne™ TMVR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...
TAVI outcomes in women with small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Modine, Nicole Karam and Sabine Bleiziffer to learn more about the latest studies regarding TAVI outcomes in women with small annuli, and to discover the results of self-expanding supra-annular TAVI compared to SAVR in this population.
Diffuse Coronary Artery Disease: RESTORE DCB – THE HYPER STUDY
18 May 2021 – From EuroPCR 2021
Watch this session presented by Alfonso Lelasi in order to have an update on the treatment of diffuse CAD involving small vessels and/or bifurcation with a novel hybrid (DES and DCB) approach, to understand the rationale of The HYPER Study (NCT03939468), and to know more about third generation RESTORE...
XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES
18 May 2021 – From EuroPCR 2021
Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.
Patent foramen ovale (PFO) closure with stroke
18 May 2021 – From EuroPCR 2021
Watch this session presented by Engin Bozkurt in order to know more about incidence about stroke caused to younger people, to follow the guideline trend towards patent foramen ovale (PFO) closure, and to learn the future of PFO and device trends.
Improving your patient's outcomes with the Edwards Benchmark program
18 May 2021 – From EuroPCR 2021
Watch this session presented by Hélène Eltchaninoff in order to understand the benefit of delivering a standardised care pathway to consistently achieve excellent outcomes, to improve access to high quality of care with safe early discharge for selected patients, in Europe, and to learn how the Edwards Benchmark...
A picture is worth a thousand words: how intravascular imaging can enhance the continuum of care
18 May 2021 – From EuroPCR 2021
Watch this session presented by Giulio Guagliumi and Tina Vilsbøll in order to understand how intravascular imaging can assess patient risk factors, how referring physicians can utilize and patients can benefit from an imaging-guided intervention, and how IVUS+NIRS images can be used as a tool to enhance patient education...
Can a pressure guidewire expand coronary physiology adoption in bifurcations?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Evald Hoi Christiansen in order to review the current major barriers to expand adoption of coronary physiology, to discover the advantages of the OptoWire III pressure guidewire in overcoming part of these barriers supporting in full safety the physiology assessments of complex PCI,...
Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Leistner in order to learn about a study investigating the long-term burden of patients with angina in a real world cohort, to understand associations between treatment decisions in the catheter laboratory and follow-up interventions, and to know about the kind and frequency...
RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension
18 May 2021 – From EuroPCR 2021
Watch this session presented by Andrew Sharp in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...
Is angio-based FFR ready to replace invasive FFR?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.
The latest on the prevail drug-coated balloon
18 May 2021 – From EuroPCR 2021
Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.
The PASCAL platform: successfully and confidently treating MR
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas van Mieghem, Fabien Praz and Peter Lüdike in order to learn about the PASCAL platform and its differentiated features, to discuss how to identify patients for the treatment with the PASCAL platform, and to review clinical data and discuss patient outcomes...
RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...
